The Course of Acute Respiratory Failure in Geriatric Patients With Hip Fracture Using Different Modes of a Vibroacoustic Device for the Lungs

NCT07517497 | Recruiting DMC

• 2 other identifiers: AP25795127Grant No.AP25795127
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

A medical professional trained in the procedure and use of the device will conduct the vibroacoustic therapy session. He will also take blood samples. In the control group, patients will undergo vibroacoustic pulmonary therapy in the "Pneumonia" mode, and in the control group, in the "Prevention" mode. Vibroacoustic pulmonary therapy will be conducted over a period of 5 days. A similar algorithm of actions is planned for both groups. VALT sessions will be conducted 4-6 times a day for 5 minutes in combination with treatment according to the protocol for the use of "Vibroacoustic Therapy" of the lungs of the Ministry of Health of the Republic of Kazakhstan. The device's emitters will be applied to the affected areas of the lungs. Since the device has long cords for the emitters and is portable, it is not difficult to change the patient's position and does not require their active participation, which is important for patients on ventilators and with limited mobility.

Conditions

Vibration; Respiratory Complications

Outcome Measures

Primary Outcomes (1)

• Arterial blood gases

  On day 1 of vibroacoustic therapy, arterial blood sampling will be performed to determine PaO2 (mmHg), PaC02 (mmHg), as well as for dynamics during transfer to the specialized department.

  Day 1

Secondary Outcomes (1)

• Chest X-ray

  Day 1

Study Arms (2)

patients will undergo Vibrolung in the "Pneumonia" mode.

OTHER

vibroacoustic physiotherapy

Device: Vibrolung

patients will undergo vibroacoustic pulmonary therapy in the "Prevention" mode.

OTHER

vibroacoustic physiotherapy

Device: Vibrolung

Interventions

Vibrolung DEVICE

BARK VibroLUNG vibroacoustic device (No. RK-MT-7No.013611 dated October 7, 2014). The device is designed for the treatment and prevention of respiratory diseases. The device operates on the principle of exposure to a powerful vibroacoustic signal generated by special emitters. During the procedure, the emitters are pressed against the surface of the chest, and the procedure lasts an average of 5 minutes. The frequency of the signal constantly changes and has complex modulation, which ensures maximum effectiveness. Depending on the selected program, the signal can cause the effect of percussion, soft vibration, smooth alternation of acoustic signal and vibration, or combinations thereof.

patients will undergo Vibrolung in the "Pneumonia" mode.; patients will undergo vibroacoustic pulmonary therapy in the "Prevention" mode.

Eligibility Criteria

• Age: 60 Years - 85 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may not qualify if:

• All contraindications for use of the device:
• terminal condition of the patient;
• shock;
• paradoxical pathological breathing;
• hypertensive crisis;
• severe hypocoagulation with a risk of hematoma formation or bleeding in the projection of exposure;
• severe hypercoagulation, risk of thrombus/embolus migration along the main vessels in the area of exposure;
• acute cerebrovascular accident in the first 1-3 days;
• brain edema;
• presence of multiple purulent or burn wound surfaces in the area of exposure;
• presence of unstable rib fractures;
• pneumomediastinum and/or subcutaneous emphysema of the chest;
• osteomyelitis of the ribs and/or thoracic spine;
• spinal fracture without orthopedic fixation;
• chest or abdominal trauma with bleeding;

Sponsors & Collaborators

• Astana Medical University: lead

Study Sites (1)

Astana medical university

Astana, 010000, Kazakhstan

RECRUITING

Central Study Contacts

Assema Bekniyazova

CONTACT

87752305441; asemabek9@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: PARTICIPANT
• Purpose: BASIC SCIENCE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Main Researcher

Model Details: The device generates electrical signals that are converted into high-intensity acoustic waves by two vibroacoustic emitters. The emitters are applied to the surface of the chest, and the sound waves propagate to the lungs, causing vibrations in the structures of the lung parenchyma. The frequency of the exposure signal constantly changes, which provides a number of effects, including the resonance effect.

Study Record Dates

• First Submitted: November 15, 2025
• First Posted: April 8, 2026
• Study Start: March 1, 2025
• Primary Completion (Estimated): December 1, 2027
• Study Completion (Estimated): December 1, 2027
• Last Updated: April 8, 2026

Record last verified: 2026-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations

KA (1)